W. R. Berkley (WRB) Stock Could Be Undervalued After Its 133% Run

W. R. Berkley has delivered a powerful long term share price gain, yet the stock has slipped over the past year, which puts fresh focus on what investors are really paying for the returns it earns on its capital. With the Excess Returns intrinsic value model centered on that question, the current price around US$67.67 invites a closer look at whether the business performance behind the ticker lines up with the market tag.

• Over the past 5 years the stock has returned about 133.4%, which raises the question of how much of that move is backed by the profitability of the capital Berkley puts to work.
• The group’s economics depend heavily on how efficiently it underwrites policies and reinvests its float, which can influence the durability of its return on equity and the cash it can reinvest versus return to shareholders.
• If you'd rather focus on earnings, this one's for you. See why W. R. Berkley's 13.6x P/E tells a different valuation story.

The stock’s next move may depend on whether the returns W. R. Berkley earns on its capital are strong enough and consistent enough to justify today’s share price.

If you are weighing whether W. R. Berkley’s 5 year return is backed by the returns it earns on its capital, it can help to compare that pattern with 30 high quality undervalued stocks.

Is W. R. Berkley a Bargain on Excess Returns?

The Excess Returns model looks at how much profit W. R. Berkley can generate above the cost of the equity on its balance sheet. For this insurer, the inputs point to a business earning more than its hurdle rate on shareholders’ capital, which helps explain why the estimated intrinsic value comes out substantially above the current US$67.67 share price.

Book Value sits at $25.31 per share and the stable Book Value estimate is $30.36 per share. Stable EPS of $5.55 per share and an Average Return on Equity of 18.27% suggest solid earnings power relative to that equity base. The model uses a Cost of Equity of $2.20 per share and an Excess Return of $3.35 per share, so it assumes W. R. Berkley can keep earning more than its funding cost on each dollar of equity, then reinvest those gains over time. Readers weighing how much of that is already reflected in the market price can compare this pattern of excess returns with. Find out what W. R. Berkley could be worth using our Excess Returns estimate.

The W. R. Berkley Narrative: What Would Justify Today's Price?

Simply Wall St Narratives pick up where the valuation work leaves off. They outline what kind of future for W. R. Berkley's growth, profitability and earnings would need to occur for the share price to look significantly higher or lower than it does today. Each narrative links its number to a specific view on how growth, margins and risks might develop over time. This way, you can refer back to those assumptions as new information appears on the Community page.

Community views on W. R. Berkley split between those who see disciplined underwriting and capital returns as enough and those who worry softer pricing will slowly bite into that story.

Bull case: roughly fairly valued

"W. R. Berkley is actively reallocating toward lines where pricing and margins are more attractive while pulling back from property and certain casualty reinsurance..."

Discover why this Narrative puts W. R. Berkley at roughly fairly valued.

Bear case: 26% overvalued

"Intensifying competition from alternative capital and insurtech entrants threatens to further pressure underwriting margins and diminish pricing power in both established and emerging insurance segments..."

Explore why this Narrative puts W. R. Berkley at 26% overvalued.

One more angle on W. R. Berkley that could change how you see it

Valuation only tells part of the story for W. R. Berkley, because the people setting underwriting discipline, capital allocation and risk appetite, and how they are rewarded for those choices, can sharply shape future outcomes. See who runs W. R. Berkley and how they are paid.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com